[Efficacy and tolerability of pantoprazole in the treatment of gastroesophageal reflux disease].
Gillessen
Anton
A
FA für Innere Medizin, Herz-Jesu-Krankenhaus Münster. Anton.Gillessen@herz-jesu-kh-ms.de
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D000077402:Pantoprazole